Addiction is one of the most intensely studied conditions in modern medicine, yet even with high‑resolution brain scans and genetic tools, scientists still cannot fully explain why some people get ...

Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...

Like many who have endured childhood trauma, Shannon Hicks turned to drugs at an early age. Pregnant by 16 and a mother of two by 19, she was married and living in her first home — believing she was ...

When considering the drugs most likely to cause former addicts to repeatedly relapse, opioids, cocaine, and methamphetamine ...

For years, addiction was seen as a matter of personal failure—a bad habit or a lack of discipline. People believed those who struggled with substance abuse could stop if they simply wanted to. But ...

It could be fertile ground for addiction, say scientists at UB’s Research Institute on Addictions (RIA). Research scientists at RIA, founded in 1970 as a part of the New York State Division of ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

1) https://www.frontiersin.org/research-topics/1036/alternative-models-of-addiction#articles – This is a link to a collection of 19 articles published in Frontiers ...

In a recent National Public Radio show on WBUR Radio Boston, Dr. Lance Dodes discussed his new book which attempts to debunk the science related to the effectiveness of 12-step mutual-help programs, ...

Members of UMSL’s Addiction Science Team assemble overdose prevention kits with doses of naloxone and information about treatment for addiction as part of their efforts to combat the opioid crisis in ...

James Kimmel, Jr., is a lecturer of psychiatry at the Yale School of Medicine, a lawyer, and the founder and co-director of the Yale Collaborative for Motive Control Studies. He is the creator of The ...